Correlation Between Cognition Therapeutics and Protalix Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Cognition Therapeutics and Protalix Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cognition Therapeutics and Protalix Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cognition Therapeutics and Protalix Biotherapeutics, you can compare the effects of market volatilities on Cognition Therapeutics and Protalix Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cognition Therapeutics with a short position of Protalix Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cognition Therapeutics and Protalix Biotherapeutics.
Diversification Opportunities for Cognition Therapeutics and Protalix Biotherapeutics
-0.41 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Cognition and Protalix is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Cognition Therapeutics and Protalix Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protalix Biotherapeutics and Cognition Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cognition Therapeutics are associated (or correlated) with Protalix Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protalix Biotherapeutics has no effect on the direction of Cognition Therapeutics i.e., Cognition Therapeutics and Protalix Biotherapeutics go up and down completely randomly.
Pair Corralation between Cognition Therapeutics and Protalix Biotherapeutics
Given the investment horizon of 90 days Cognition Therapeutics is expected to under-perform the Protalix Biotherapeutics. In addition to that, Cognition Therapeutics is 1.04 times more volatile than Protalix Biotherapeutics. It trades about -0.19 of its total potential returns per unit of risk. Protalix Biotherapeutics is currently generating about 0.33 per unit of volatility. If you would invest 113.00 in Protalix Biotherapeutics on August 29, 2024 and sell it today you would earn a total of 55.00 from holding Protalix Biotherapeutics or generate 48.67% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cognition Therapeutics vs. Protalix Biotherapeutics
Performance |
| Timeline |
| Cognition Therapeutics |
| Protalix Biotherapeutics |
Cognition Therapeutics and Protalix Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cognition Therapeutics and Protalix Biotherapeutics
The main advantage of trading using opposite Cognition Therapeutics and Protalix Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cognition Therapeutics position performs unexpectedly, Protalix Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protalix Biotherapeutics will offset losses from the drop in Protalix Biotherapeutics' long position.| Cognition Therapeutics vs. Eliem Therapeutics | Cognition Therapeutics vs. Scpharmaceuticals | Cognition Therapeutics vs. Milestone Pharmaceuticals | Cognition Therapeutics vs. Seres Therapeutics |
| Protalix Biotherapeutics vs. Corvus Pharmaceuticals | Protalix Biotherapeutics vs. Aldeyra | Protalix Biotherapeutics vs. Checkpoint Therapeutics | Protalix Biotherapeutics vs. Cidara Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |